Ligand Pharmaceuticals Inc (NAS:LGND)
$ 122.55 -1.78 (-1.43%) Market Cap: 2.32 Bil Enterprise Value: 2.10 Bil PE Ratio: 48.82 PB Ratio: 2.73 GF Score: 75/100

Q4 2023 Ligand Pharmaceuticals Inc Earnings Call Transcript

Feb 27, 2024 / 01:30PM GMT
Release Date Price: $89.2 (+19.86%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome everyone to the Ligand Fourth Quarter 2023 earnings webcast.

At this time, all lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press the star followed by the number one on your telephone keypad. If you'd like to withdraw your question, please press the star followed by the one.

Once again. Thank you. I will now hand the call over to Teva Aspen dozer, Chief Financial Officer. You may begin your conference.

Octavio Espinoza
Ligand Pharmaceuticals Inc - Chief Financial Officer

Hello, everyone, and welcome to our earnings call for the fourth quarter and year-end 2023. During the call today, we will review the financial results we released prior to today's market opens and offer commentary on our partnered pipeline and business development activity, after which we will host a question and answer session. Our earnings release can be found in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot